Clinical Trials Market
Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, and Phase IV), by Study Design (Interventional, Observational, and Expanded Access), by Therapeutic Area (Autoimmune Disease, Oncology, Cardiology, Infectious Disease, Dermatology, Ophthalmology, and Others) and by Sponsor Outlook (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Others) Forecast Period (2022-2028)
Clinical trials market is anticipated to grow at a significant CAGR of 5.3% during the forecast period. The key factors contributing to the market growth include increasing advancement in products by the addition of various technologies in a product such as new software, system to monitor clinical trials that take fewer times and attributed to the demand for the various new technologies and growing and also adoption is increasing that in turn contributing in the positive growth of the market. For instance, in May 2020, Royal Philips launched Clinical Trial Accelerator on Philips HealthSuite which allows life science organizations to integrate, analyze and store clinical and patient-reported data and also assist in faster decision-making. In addition, in December 2019, Teckro launched new software to streamline clinical trials, which uses machine-learning technology to transform clinical trial protocols from static documents into actionable data. This software provides feedback to improve performance, software additions can accelerate the speed and precision and also gives study administrators a consistent way to communicate.
Segmental Outlook
The global clinical trials market is segmented based on the phase, study design, therapeutic area, and sponsor outlook. Based on this the market is segmented into phase I, phase II, phase III, and phase IV. Based on the study design, the market is segmented into interventional, observational, and expanded access. Based on the therapeutic area, the market is segmented into autoimmune disease, oncology, cardiology, infectious disease, dermatology, ophthalmology, and others. Based on the sponsor outlook, the market is subdivided into pharmaceutical & biopharmaceutical companies, medical device companies, and others. Among study design, the interventional segment is anticipated to hold a prominent share in the market owing to it is the most widely used method in clinical trials, this method is an improved way of measuring the efficacy of new intermediation, and also several advantages such as information on exposure are gained before disease develops among others are such factors that are driving segmental growth further in the market.
Among the therapeutic area, the oncology segment is predicted to hold a prominent share in the market attributed to the growing prevalence of cancer across the globe, one-by-one ongoing clinical research activities and new drugs under pipeline, and increasing government funding for oncology therapeutic areas are such factors driving oncology segment growth in the market. For instance, in June 2022, the Australian Government Department of Health and Aged Care provided $13.6 million in funding to support 10 clinical trials researching innovative cancer treatments for several cancer that includes, including melanoma, reproductive and gynecological cancers, and childhood brain cancer. Moreover, increasing innovation in clinical trial methods and databases For instance, in August 2021, Targeted Oncology launched its new clinical trial database, that provides expert insights into ongoing clinical trials. The newly developed site serves as a first-of-its-kind resource for community oncologists and they have the option to filter by both state and disease by which they can offer additional information on ongoing trials that are available to patients.
Regional Outlooks
The global clinical trials market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East &Africa, and Latin America. The North America region is estimated to hold a prominent share owing to increasing demand for outsourcing clinical trials to CROs, increasing government and non-government funding for clinical trials is driving market growth further in the region.
Global Clinical Trials Market Growth, by Region 2022-2028
The Asia-Pacific Region is Fastest Growing in the Global Clinical Trials Market
The region is estimated to witness the fastest growth in the market owing to increasing government investment in research and raising awareness regarding precision medicine, raising several biotechnology firms are such factors driving regional growth in the market. For instance, in May 2021, IQVIA expanded its base into Japan and the Asia Pacific as IQVIA Biotech to deliver integrated clinical and commercial solutions for biotech and emerging biopharma companies. The company by expansion is supporting the aspirations of biotech customers with agile solutions and resources dedicated to supporting smaller companies In addition, in September 2020, India started science diplomacy an initiative by launching a program under which the Department of Biotechnology is set to strengthen the capacity of clinical trial research of vaccines in neighboring countries Amid the COVID-19 pandemic.
Market Players Outlook
The major companies serving the global clinical trials market include AccuLab Life Sciences, Charles River Laboratories International, Inc., Eli Lilly and Co., Labcorp, Parexel International GmbH, Pfizer Inc., WuXi AppTec Co., Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, geographical expansions, partnerships, product launches, and collaborations, to stay competitive in the market. For instance, in March 2021, Advarra acquired Bio-Optronics, to connect the clinical trial ecosystem – sponsors, clinical research organizations (CROs) and sites throughout which the company can make clinical research safer, smarter, and faster. The company further powers the work of over 50,000 investigators in the clinical trial ecosystem and also includes a clinical trial management system (CTMS) for health systems and research sites.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global clinical trials market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Charles River Laboratories International, Inc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Eli Lilly and Co.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Labcorp
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Pfizer Inc.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. WuXi AppTec Co., Ltd.
3.6.1. Overview
3.6.2. Financial Analysis
3.6.3. SWOT Analysis
3.6.4. Recent Developments
3.7. Key Strategy Analysis
4. Market Segmentation
4.1. Global Clinical Trials Market by Phase
4.1.1. Phase I
4.1.2. Phase II
4.1.3. Phase III
4.1.4. Phase IV
4.2. Global Clinical Trials Market by Study Design
4.2.1. Interventional
4.2.2. Observational
4.2.3. Expanded Access
4.3. Global Clinical Trials Market by Therapeutic Area
4.3.1. Autoimmune Disease
4.3.2. Oncology
4.3.3. Cardiology
4.3.4. Infectious Disease
4.3.5. Dermatology
4.3.6. Ophthalmology
4.3.7. Others (Women's Health, Genetic Diseases, and Immunology)
4.4. Global Clinical Trials Market by Sponsor Outlook
4.4.1. Pharmaceutical & Biopharmaceutical Companies
4.4.2. Medical Device Companies
4.4.3. Others (Academic Medical Centers, Industry-Sponsored)
5. Regional Analysis
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. AccuLab Life Sciences
6.2. BioAgile Therapeutics Pvt Ltd.
6.3. Celerion
6.4. Clario
6.5. Dove Quality Solutions Ltd.
6.6. Firma Clinical Research (Firma)
6.7. Frontage Laboratories, Inc.
6.8. Geneticist Inc
6.9. ICON plc
6.10. IQVIA
6.11. Linical Americas
6.12. Medpace, Inc.
6.13. Novo Nordisk A/S
6.14. Novotech
6.15. Parexel International GmbH
6.16. Pepgra
6.17. PSI CRO AG
6.18. SGS
6.19. Syneos Health
6.20. Thermo Fisher Scientific
1. GLOBAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY PHASE, 2021-2028 ($ MILLION)
2. GLOBAL PHASE I CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL PHASE II CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL PHASE III CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL PHASE IV CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY STUDY DESIGNS, 2021-2028 ($ MILLION)
7. GLOBAL INTERVENTIONAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL OBSERVATIONAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL EXPANDED ACCESS CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC AREA, 2021-2028 ($ MILLION)
11. GLOBAL AUTOIMMUNE DISEASE CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL INFECTIOUS DISEASE CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL ONCOLOGY CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL CARDIOLOGY CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL DERMATOLOGY CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL OPHTHALMOLOGY CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17. GLOBAL OTHERS CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18. GLOBAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY SPONSOR OUTLOOK, 2021-2028 ($ MILLION)
19. GLOBAL CLINICAL TRIALS IN PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
20. GLOBAL CLINICAL TRIALS IN MEDICAL DEVICE COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
21. GLOBAL CLINICAL TRIALS IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
22. GLOBAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
23. NORTH AMERICAN CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
24. NORTH AMERICAN CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY PHASE, 2021-2028 ($ MILLION)
25. NORTH AMERICAN CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY STUDY DESIGN, 2021-2028 ($ MILLION)
26. NORTH AMERICAN CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC AREA, 2021-2028 ($ MILLION)
27. NORTH AMERICAN CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY SPONSOR OUTLOOK, 2021-2028 ($ MILLION)
28. EUROPEAN CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
29. EUROPEAN CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY PHASE, 2021-2028 ($ MILLION)
30. EUROPEAN CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY STUDY DESIGN, 2021-2028 ($ MILLION)
31. EUROPEAN CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC AREA, 2021-2028 ($ MILLION)
32. EUROPEAN CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY SPONSOR OUTLOOK, 2021-2028 ($ MILLION)
33. ASIA-PACIFIC CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
34. ASIA-PACIFIC CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY PHASE, 2021-2028 ($ MILLION)
35. ASIA-PACIFIC CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY STUDY DESIGN, 2021-2028 ($ MILLION)
36. ASIA-PACIFIC CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC AREA, 2021-2028 ($ MILLION)
37. ASIA-PACIFIC CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY SPONSOR OUTLOOK, 2021-2028 ($ MILLION)
38. REST OF THE WORLD CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
39. REST OF THE WORLD CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY PHASE, 2021-2028 ($ MILLION)
40. REST OF THE WORLD CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY STUDY DESIGN, 2021-2028 ($ MILLION)
41. REST OF THE WORLD CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC AREA, 2021-2028 ($ MILLION)
42. REST OF THE WORLD CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY SPONSOR OUTLOOK, 2021-2028 ($ MILLION)
1. GLOBAL CLINICAL TRIALS MARKET SHARE BY PHASE, 2021 VS 2028 (%)
2. GLOBAL PHASE I CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
3. GLOBAL PHASE II CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
4. GLOBAL PHASE III CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
5. GLOBAL PHASE IV CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL CLINICAL TRIALS MARKET SHARE BY STUDY DESIGN, 2021 VS 2028 (%)
7. GLOBAL INTERVENTIONAL CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL OBSERVATIONAL CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL EXPANDED ACCESS CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL CLINICAL TRIALS MARKET SHARE BY THERAPEUTIC AREA, 2021 VS 2028 (%)
11. GLOBAL AUTOIMMUNE DISEASE CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL INFECTIOUS DISEASE CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL ONCOLOGY CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL CARDIOLOGY CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL DERMATOLOGY CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL OPHTHALMOLOGY CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL OTHERS CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. GLOBAL CLINICAL TRIALS MARKET SHARE BY SPONSOR OUTLOOK, 2021 VS 2028 (%)
19. GLOBAL CLINICAL TRIALS IN PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
20. GLOBAL CLINICAL TRIALS IN MEDICAL DEVICE COMPANIES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
21. GLOBAL CLINICAL TRIALS IN OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
22. GLOBAL CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
23. GLOBAL CLINICAL TRIALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
24. US CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
25. CANADA CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
26. UK CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
27. FRANCE CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
28. GERMANY CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
29. ITALY CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
30. SPAIN CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
31. REST OF EUROPE CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
32. INDIA CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
33. CHINA CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
34. JAPAN CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
35. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
36. REST OF ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
37. REST OF THE WORLD CLINICAL TRIALS MARKET SIZE, 2021-2028 ($ MILLION)
